Single vaccination approach developed to combat respiratory diseases
23 May 2019 | By European Pharmaceutical Review
Scientists have developed a single vaccination approach to simultaneously combat influenza and pneumococcal infections.
List view / Grid view
Vaccines
Tuberculosis: fighting the disease with a single vial
13 May 2019 | By Christopher Fox, Dr Daniel Hoft
Vaccinations have begun in a phase I human clinical trial testing a freeze-dried, temperature-stable formulation of an experimental tuberculosis vaccine candidate. Nikki Withers speaks to Dr Daniel Hoft and Christopher Fox about the formulation process and what this means for vaccine development going forward.
Novel colorectal cancer vaccine shows positive phase I results
2 May 2019 | By European Pharmaceutical Review
A new vaccine for colorectal cancer has proven to be safe in a small sample of human subjects, opening the way for the next phase of testing.
$100 million is to be invested to increase vaccine manufacturing in US
30 April 2019 | By European Pharmaceutical Review
A $100 million investment has been made to support long-term vaccine manufacturing capabilities in the US.
Guide To Testing
26 April 2019 | By European Pharmaceutical Review
In this edition of our ‘Guide to’ series, learn how these leading companies’ services and expertise can help you test your pharma/ biopharma products and medical devices.
Formulation In-Depth Focus 2019
26 April 2019 | By European Pharmaceutical Review
As today’s scientists continue to identify new biopharmaceutical products with potential to treat a wide array of diseases, formulation remains the determining factor in their success. But what is involved in these increasingly complex formulation processes and how do they impact the packaging and delivery systems?
European Pharmaceutical Review Issue 2 2019
25 April 2019 | By European Pharmaceutical Review
This issue questions whether companies are sufficiently investing in regulatory intelligence software and what the potential consequences of Brexit might be for locations outside of the UK and EU. The issue also features articles on microbiology, formulation and biopharma, courtesy of our in-depth focus sections; as well as outlining the…
Landmark Malaria vaccine pilot programme launched in Malawi
25 April 2019 | By European Pharmaceutical Review
The Government of Malawi has launched the world’s first malaria vaccine which will be made available to children up to two years of age.
Europe-Africa partnership spearheads development of next-generation antimalarial drug
18 April 2019 | By Nikki Withers (European Pharmaceutical Review)
The grant will support African trials of a novel antimalarial combination comprising KAF156 (ganaplacide) and lumefantrine in a new once-daily formulation...
Further advances in cell-based influenza vaccine technology announced
17 April 2019 | By European Pharmaceutical Review
An influenza vaccine manufacturer has announced it is filing an Annual Strain Update with the US Food and Drug Administration (FDA) in the coming weeks due to advances in influenza vaccine technology.
Flyer: Biologicals drug substance and drug product
20 February 2019 | By Eurofins CDMO
Eurofins CDMO provides a full suite of drug development services encompassing development of the bioprocesses, formulation screening, analytical development, pre-clinical testing, sterile and non-sterile bio-manufacturing of clinical trial batches and orphan drugs.
Micromotors used for the delivery of oral vaccines
6 February 2019 | By European Pharmaceutical Review
Researchers have developed a method of using micromotors to deliver oral vaccines in an attempt to break away from widely used injections...
Making liposomal formulations for the delivery of RNA vaccines
25 January 2019 | By Dolomite Microfluidics
A Dolomite Microfluidics’ set-up for high throughput single cell encapsulation is helping researchers at the Department of Medicine at Imperial College, London, to develop novel liposomal formulations for RNA vaccines targeting diseases such as HIV, influenza, rabies and chlamydia...
Freeze-dried TB vaccine candidate enters Phase 1 human clinical trial
24 January 2019 | By Nikki Withers (European Pharmaceutical Review)
A vaccine that does not require a cold chain could be much more easily distributed to communities in need…
Further scandal for China’s pharmaceutical industry
14 January 2019 | By Nikki Withers (European Pharmaceutical Review)
Chinese police say they have opened an investigation into reports that at least 145 children received an expired polio vaccine...
Follow: